levofloxacin (Quinsair) -

levofloxacin (Quinsair)
Information type: Drug best practice guidance
Source: Scottish Medicines Consortium
Specialities: Infection and infectious diseases | Respiratory disorders
Summary
Levofloxacin nebuliser solution is accepted for restricted use within NHS Scotland the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis.
UKMi comment
Use is restricted to third line treatment after colistimethate sodium (first line) and tobramycin (second line).
Related links:

Terms and Conditions

For feedback or enquiries relating to this service please email: medicinesresources@gstt.nhs.uk